AKT1 and Hepatic fibrosis: (2021) showed that base on network pharmacology combination with transcriptomics analysis to develop a novel anti-liver fibrosis new formula from Xiaoyaosan decoction, and its anti-liver fibrosis function may be related to the regulation of PI3K/AKT and JAK/STAT signalling.